ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

AAMI Aligns With National Academy of Medicine AI Code of Conduct

Arlington, VA, July 03, 2025 (GLOBE NEWSWIRE) -- The Association for the Advancement of Medical Instrumentation (AAMI) today announces its alignment with the National Academy of Medicine’s (NAM) recently published AI Code of Conduct (AICC). AAMI intends to leverage the Code to inform its work addressing the use of artificial intelligence and machine learning in medical devices.

Entitled An Artificial Intelligence Code of Conduct for Health and Medicine: Essential Guidance for Aligned Action, the AICC is a non-binding resource that organizations in the medical field can use as a baseline for evaluating AI adoption and deployment. The Code identifies six core commitments for any ethical application and implementation of AI in the medical field.

  1. Advance Humanity
  2. Ensure Equity
  3. Engage Impacted Individuals
  4. Improve Workforce Well-Being
  5. Monitor Performance
  6. Innovate and Learn

“AI has the potential to further transform health care, but where there is opportunity there is also risk,” noted Robert Burroughs, AAMI’s Chief Learning and Development Officer. “As the leading developer of voluntary, consensus standards for the medical device industry, our mission is to help ensure the safe and effective use of health technology. The AICC’s six core principles provide a framework we can use to align our diverse efforts across standards development, education, and certification. We intend to use the AICC as a key reference document and will share it widely with our members and stakeholders."

AAMI Vice President of Standards, Matt Williams, also anticipates clear benefits for AAMI. “We fully expect the AICC will provide a welcome resource for AAMI Committee members as they produce regulatory-ready guidance documents for the entire medical device sector.”

Laura Adams, Senior Advisor at the National Academy of Medicine, describes the AICC as a “definitive answer to a disjointed landscape” of AI guidelines and frameworks. Describing its six commitments, she noted that readers “find them to be practical. We clarified them, we elevated what was out in the field, and we are finding that people are using [the AICC] as a touchstone.”

In an effort to facilitate the adoption of these essential guidelines, Adams has authored a guide titled “Why and How to Use the NAM AICC.” To further accelerate adoption, AAMI is also producing an executive summary of the 189-page AICC later this year.

The rigorous NAM development process involves an extensive field review that brings together the world’s leading experts. Among the experts who contributed to the AICC were Google’s Senior Director of Global Digital Health Strategy & Regulatory and AAMI board member Bakul Patel, Pat Baird, Regulatory Head of Global Software Standards at Philips, who serves as co-chair of AAMI’s AI Committee, and AAMI’s Vice President of Industry and Emerging Technologies, Timothy Hsu.

Do you have questions for the AAMI staffers or members who contributed to the National Academy of Medicine’s AI Code of Conduct? Get in touch with AAMI’s communications team at dvisnovsky@aami.org.


Primary Logo

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.